Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

KALV holding history

KalVista Pharmaceuticals, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KALV overviewAll 13F holders of KALVFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of KALV by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−996,235−100.0%Sold outHolders
Q1 2026996,235$20.1M<0.1%+52,158+5.5%AddedHolders
Q4 2025944,077$15.3M<0.1%+15,406+1.7%AddedHolders
Q3 2025928,671$11.3M<0.1%−12,541−1.3%ReducedHolders
Q2 2025941,212$10.6M<0.1%+25,971+2.8%AddedHolders
Q1 2025915,241$10.6M<0.1%+92,889+11.3%AddedHolders
Q4 2024822,352$6.97M<0.1%−8,632−1.0%ReducedHolders
Q3 2024830,984$9.62M<0.1%+24,713+3.1%AddedHolders
Q2 2024806,271$9.50M<0.1%+154,383+23.7%AddedHolders
Q1 2024651,888$7.73M<0.1%+21,840+3.5%AddedHolders
Q4 2023630,048$7.72M<0.1%+108,157+20.7%AddedHolders
Q3 2023521,891$5.03M<0.1%+41,466+8.6%AddedHolders
Q2 2023480,425$4.32M<0.1%+12,941+2.8%AddedHolders
Q1 2023467,484$3.67M<0.1%+69,409+17.4%AddedHolders
Q4 2022398,075$2.69M<0.1%−16,784−4.0%ReducedHolders
Q3 2022414,859$6.02M<0.1%+17,844+4.5%AddedHolders
Q2 2022397,015$3.91M<0.1%−12,011−2.9%ReducedHolders
Q1 2022409,026$6.03M<0.1%+31,056+8.2%AddedHolders
Q4 2021377,970$5.00M<0.1%+9,830+2.7%AddedHolders
Q3 2021368,140$6.42M<0.1%+30,863+9.2%AddedHolders
Q2 2021337,277$8.08M<0.1%+10,010+3.1%AddedHolders
Q1 2021327,267$8.41M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.